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AutophagyObesity-induced cardiomyopathymay bemediated by alterations inmultiple signaling cascades involved in glu-
cose and lipidmetabolism. Protein tyrosine phosphatase-1B (PTP1B) is an important negative regulator of insulin
signaling. This studywas designed to evaluate the role of PTP1B inhigh fat diet-induced cardiac contractile anom-
alies. Wild-type and PTP1B knockout mice were fed normal (10%) or high (45%) fat diet for 5 months prior to
evaluation of cardiac function. Myocardial function was assessed using echocardiography and an Ion-Optix
MyoCam system. Western blot analysis was employed to evaluate levels of AMPK, mTOR, raptor, Beclin-1, p62
and LC3-II. RT-PCR technique was employed to assess genes involved in hypertrophy and lipid metabolism.
Our data revealed increased LV thickness and LV chamber size as well as decreased fractional shortening follow-
ing high fat diet intake, the effectwas nulliﬁed by PTP1B knockout. High fat diet intake compromised cardiomyo-
cyte contractile function as evidenced by decreased peak shortening, maximal velocity of shortening/
relengthening, intracellular Ca2+ release as well as prolonged duration of relengthening and intracellular Ca2+
decay, the effects of which were alleviated by PTP1B knockout. High fat diet resulted in enlarged cardiomyocyte
area and increased lipid accumulation,whichwere attenuated by PTP1B knockout. High fat diet intake dampened
myocardial autophagy as evidenced by decreased LC3-II conversion and Beclin-1, increased p62 levels as well as
decreased phosphorylation of AMPK and raptor, the effects of which were signiﬁcantly alleviated by PTP1B
knockout. Pharmacological inhibition of AMPK using compound C disengaged PTP1B knockout-conferred protec-
tion against fatty acid-induced cardiomyocyte contractile anomalies. Taken together, our results suggest that
PTP1B knockout offers cardioprotection against high fat diet intake through activation of AMPK. This article is
part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic diseases.y and protein quality control in
iovascular Diseases, Zhongshan
ijun@zs-hospital.sh.cn (A. Sun).© 2014 Elsevier B.V. All rights reserved.1. Introduction
Obesity and type 2 diabetesmellitus are growing at an alarming rate
in all age groups. Approximately 35% of US population is considered
obese or overweight while nearly 26 million people suffer from type 2
diabetes with many undiagnosed [1–4]. Obesity and type 2 diabetes
are major risk factors for the onset and development of cardiovascular
complication leading to high morbidity and mortality in thesepopulations [5]. Among various contributing factors for obesity and
type 2 diabetes, insulin resistance plays a central role in the develop-
ment of organ complications in obesity and type 2 diabetes [5,6]. Several
mechanisms have been postulated for the etiology of insulin resistance
including JNK activation [7–9], protein kinase C induction [10,11], oxi-
dative stress [6,12,13], altered substrate metabolism [6,14] and activa-
tion of protein tyrosine phosphatase 1B (PTP1B) [15]. PTP1B is the
prototype for the superfamily of PTPs with a role in the regulation of
insulin, leptin and adiponectin to govern food intake and metabolism
[16–19]. PTP1B negatively regulates insulin action via dephosphoryla-
tion of autophosphorylated insulin receptor and downstream insulin
substrate proteins such as IRS-1/2. PTP1B also affects insulin signaling
via regulation of cellular redox state [20]. Similarly PTP1B negatively
regulates leptin signaling by dephosphorylation of leptin receptor asso-
ciated Janus kinase 2 [21–23]. It has been demonstrated that PTP1B
regulates body mass and adiposity mainly through its actions in the
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tion and govern the development of leptin resistance [19,23]. The
tight correlation between PTP1B variants and prevalence of obesity or
type 2 diabetes makes PTP1B a rather interesting and important drug
target in the management of obesity and type 2 diabetes [24]. To this
end, our present work was designed to examine the impact of PTP1B
deletion on chronic fat diet intake-induced cardiac geometric and
functional anomalies as well as the possible signaling mechanisms
involved.
Autophagy is a self-conservative cellular mechanism to degrade and
recycle unwanted or damaged cell debris including macromolecules,
organelles and nutrients. Autophagy participates in physiological and
pathophysiological responses such as adaptation to starvation,
intracellular protein and damaged organelle clearance, development,
aging, defense against microorganisms and cell death [25]. Under nor-
mal physiological conditions, autophagy serves as an essential house-
keeper to maintain homeostasis for multiple organs including the
heart [26]. However, autophagy becomes dysfunctional under patho-
logical conditions such as ischemia/reperfusion, cardiac hypertrophy,
endoplasmic reticulum (ER) stress and heart failure [27,28]. Given the
controversy of autophagy in obesity and obesity complications, the
role of autophagy and autophagy regulatory mechanism(s) was exam-
ined in PTP1B deletion-induced cardiac response, if any, in the face of
chronic high fat diet intake.
2. Materials and methods
2.1. Experimental animals and high fat diet feeding
All animal procedures described in this study were approved by the
Animal Care and Use Committee at the University of Wyoming (Lara-
mie, WY). PTP1B whole body knockout mice with a background of
C57BL/6Jwere kindly providedbyDr.ML. Tremblay (McGill Cancer Cen-
ter, Quebec, Canada). In brief, animals were housed under temperature-
controlled condition (22 ± 2 °C), humidity (55 ± 5%) and a 12 h/12 h
light–dark circadian cycle with access to food and water ad libitum.
Five-week-old male PTP1B knockout (PTP1BKO) mice and their
wild-type littermates were subjected to a normal (10% calories
from fat, 3.91 kcal/g) or high fat (45% calories from fat, 4.83 kcal/g;
Research Diets, New Brunswick, NJ) diet feeding for 20 weeks [29].
Plasma levels of glucose and insulin were measured using commer-
cial kits.
2.2. Echocardiographic assessment
Cardiac geometry and contractile function were evaluated in anes-
thetized (ketamine 80 mg/kg and xylazine 12 mg/kg, i.p.) mice using
the 2-D guided M-mode echocardiography (Phillips Sonos 5500)
equippedwith a 15–6MHz linear transducer (PhillipsMedical Systems,
Andover, MD). Left ventricular (LV) anterior and posterior wall dimen-
sions during diastole and systole were recorded from three consecutive
cycles inM-mode using themethod adopted by the American Society of
Echocardiography. Fractional shortening was calculated from LV end-
diastolic (EDD) and end-systolic (ESD) diameters using the equation
(EDD− ESD) / EDD. Heart rates were averaged over 10 cycles [30].
2.3. Murine cardiomyocyte isolation
After ketamine/xylazine sedation, hearts were removed and per-
fused with Ca2+-free Tyrode's solution pH 7.4 containing (in mM):
NaCl 135, KCl 4.0, MgCl2 1.0, HEPES 10, NaH2PO4 0.33, NaHCO3 4.6,
glucose 10, butanedione monoxime 10, and the solution was gassed
with 5% CO2/95% O2. Hearts were digested with Liberase Blendzyme 4
(Hoffmann-La Roche Inc., Indianapolis, IN) for 20 min. Left ventricles
were removed and minced before being ﬁltered. Myocardial tissue
pieces were gently agitated and pellet of cells was resuspended.Extracellular Ca2+was added incrementally back to 1.20mMover a pe-
riod of 30 min. Isolated myocytes were used within 8 h of isolation. A
yield of 50–60% viable rod-shaped cardiomyocytes (~75–80% in purity
for cardiomyocytes) with clear sarcomere striations was achieved and
the cells were used for mechanical study [31].
2.4. Cell shortening and relengthening
Mechanical properties of cardiomyocytes were assessed using a
SoftEdge MyoCam system (IonOptix, Milton, MA) [31]. In brief, cells
were placed in aWarner chambermounted on the stage of an inverted
microscope (Olympus IX-70) and superfused (~1 ml/min at 25 °C)
with a buffer containing (in mM) 131 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2,
10 glucose, and 10 HEPES at pH 7.4. Cells were ﬁeld stimulated with
suprathreshold voltage at a frequency of 0.5 Hz using a pair of plati-
num wires placed on opposite sides of the chamber connected to an
FHC stimulator (Brunswick, NE). The myocyte being studied was
displayed on the computer monitor using an IonOptix MyoCam cam-
era. An IonOptix SoftEdge software was used to capture changes in
cell length during shortening and relengthening. For in vitro experi-
ment, isolated cardiomyocytes were treated for 2 h with palmitic
acid (75 μM) dissolved in 0.06% BSA [32,33]. Cell shortening and
relengthening were assessed using the indices including cell length,
peak shortening (PS), maximal velocity of shortening/relengthening
(±dL/dt), time-to-PS (TPS), and time-to-90% relengthening (TR90).
2.5. Intracellular Ca2+ transients
Isolated cardiomyocytes were loaded with Fura-2/AM (0.5 μM)
for 10 min, and ﬂuorescence intensity was recorded with a dual-
excitation ﬂuorescence photomultiplier system (IonOptix).
Myocytes were placed onto an Olympus IX-70 inverted microscope
and imaged through a Fluor 40× oil objective. Cells were exposed
to light emitted by a 75-W lamp and passed through either a 360-
or a 380-nm ﬁlter while being stimulated to contract at 0.5 Hz. Fluo-
rescence emissions were detected between 480 and 520 nm, and
qualitative change in Fura-2 ﬂuorescence intensity was inferred
from the Fura-2 ﬂuorescence intensity ratio at the two wavelengths
(360/380). Fluorescence decay time was calculated as an indicator
of intracellular Ca2+ clearing [31].
2.6. Cardiac histological analysis and oil red staining
Following anesthesia, hearts were excised and immediately placed
in 10% neutral-buffered formalin at room temperature for 24 h after a
brief rinse with PBS. The specimen were embedded in parafﬁn, cut in
5-μm sections and stained with the FITC-conjugated wheat germ agglu-
tinin. Cardiomyocyte cross-sectional areas were calculated on a digital
microscope (×400) using the Image J (ver1.34S) software. For oil-red-
O staining, hearts were sliced and snap-frozen in isopentane-cooled liq-
uid nitrogen before cutting into 10-μmsectionswith a cryostat. The sec-
tions were ﬁxed with 10% neutral-buffered formalin, rinsed with 60%
isopropanol and stained with oil-red-O for 15 min. After rinsing with
isopropanol, sections were counterstained and mounted with aqueous
mountant (Vector Laboratories Ltd., Burlingame, CA). A digital Olympus
BX-51 microscope (×400) (Olympus America Inc., Melville, NY) was
used to digitalize the sections [34,35].
2.7. Assessment of mRNA expression by quantitative real-time PCR
Total RNA was isolated from left ventricles followed by DNase
digestion to eliminate genomic DNA contamination. Synthesis of cDNA
wasperformed at 37 °C for 60minusing1 μg total RNA in a 20-μl system
by Superscript III. Quantitative real-time RT-PCR analysis was per-
formed for α-myosin heavy chain (α-MHC), β-myosin heavy chain
(β-MHC), atrial natriuretic factor (ANF), brain natriuretic peptide
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Fig. 1. Effect of PTP1B knockout on high fat diet (HFD)-induced echocardiographic changes. WT and PTP1BKO mice were fed normal diet (ND) or high fat diet for 20 weeks prior to the
assessment of biometric and echocardiographic parameters. A: Body weight; B: heart weight; C: representative echocardiographic images in WT and PTP1BKO mice fed ND or HFD for
20 weeks (vertical lines with arrowhead ending denote measurement of LVEDD and LVESD); D: fractional shortening (%); E: LVEDD; F: LVESD; and G: LV wall thickness. Mean ± SEM,
n = 8 mice per group, *p b 0.05 vs. WT-ND group, #p b 0.05 vs. WT-HFD group.
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protein 1 (SREBP1c), peroxisome proliferator-activated receptor-α
(PPARα), peroxisome proliferator-activated receptor-γ (PPARγ) and
GAPDH (housekeeping gene) [36].
2.8. Western blotting
Protein samples for Western blotting were prepared as described
previously [37]. In brief, ventricular tissues were homogenized and
sonicated in a lysis buffer containing 20 mM Tris (pH 7.4), 150mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM
ethyleneglycoltetraacetic acid (EGTA), 1% Triton, 0.1% SDS, and 1%
protease inhibitor cocktail. The protein concentration of the superna-
tant was evaluated using a protein assay reagent (500-0006; Bio-Rad
Laboratories, Hercules, CA). Protein samples were then mixed 1:2
with Laemmli sample buffer with 5% 2-mercaptoethanol and heated
at 95 °C for 5 min. Equal amounts (50 μg) of proteins were separated
on 7%, 10%, 12% or 15% SDS–polyacrylamide gels in a minigel apparatus
(Mini-PROTEAN II, Bio-Rad) andwere transferred electrophoretically to
nitrocellulose membranes (0.2 μm pore size, Bio-Rad). Membranes
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Fig. 2. Effect of PTP1B knockout on high fat diet (HFD)-induced changes in cardiomyocyte contractile function.WT andPTP1BKOmicewere fedNDor high fat diet for 20 weeks prior to the
assessment of cardiomyocyte function. A: Representative cell shortening traces from WT-ND and WT-HFD groups; B: representative cell shortening traces from PTP1BKO-ND and
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buffered saline (TBS).Membranes werewashed brieﬂy in TBS and incu-
bated overnight at 4 °Cwith anti-PTP1B (1:1000), anti-AMPK (1:1000),
anti-p-AMPK (Thr172, 1:1000), anti-mTOR (1:1000), anti-p-mTOR
(Ser2448, 1:1000), anti-raptor (1:1000), anti-p-raptor (Ser792,
1:1000), anti-Atg5 (1:1000), anti-Beclin-1 (1:1000), anti-P62
(1:1000), anti-LC3B (1:1000), and anti-GAPDH (1:1000) antibodies.
All antibodies were obtained from Cell Signaling Technology (Beverly,
MA). After washing blots to remove excessive primary antibody bind-
ing, blots were incubated for 1 h with horseradish peroxidase (HRP)-
conjugated secondary antibody (1:2500). Antigens were detected by
the luminescence method. Quantiﬁcation of band density was deter-
mined using Quantity One software (Bio-Rad, version 4.4.0, ChemiDoc
XRS) and reported in optical density per square millimeter [36].2.9. Statistical analysis
Data were expressed as mean ± SEM. Statistical signiﬁcance
(p b 0.05) was estimated by analysis of variance followed by Tukey's
test for post hoc analysis.
3. Results
3.1. Effect of PTP1B knockout on cardiac function following high fat diet
feeding
Our data shown in Fig. 1 depicted comparable body and heart
weights between WT and PTP1B knockout mice fed normal diet. High
fat diet feeding for 20 weeks signiﬁcantly increased body weight and
303M.R. Kandadi et al. / Biochimica et Biophysica Acta 1852 (2015) 299–309heart weight-to-tibial length ratio, the effects of which were ablated by
PTP1B knockout. Plasma glucose levels were comparable in all groups
(WT-ND: 90 ± 7 mg/dl; WT-HFD: 99 ± 12 mg/dl; PTP1BKO-ND:
86 ± 13 mg/dl; PTP1BKO-HFD: 98 ± 4 mg/dl; p N 0.05). High fat diet
feeding overtly elevated plasma insulin levels in a comparable manner
in WT and PTP1B knockout mice (WT-ND: 0.27 ± 0.03 mg/dl; WT-
HFD: 0.55 ± 0.04 mg/dl; PTP1BKO-ND: 0.29 ± 0.02 mg/dl; PTP1BKO-
HFD: 0.46 ± 0.04 mg/dl; p b 0.05 between ND and HFD groups). Echo-
cardiographic analysis revealed that high fat diet intake signiﬁcantly de-
creased fractional shortening as well as increased LV end diastolic
diameter (LVEDD), LV end systolic diameter (LVESD) and wall thick-
ness. Although PTP1B knockout failed to elicit any notable effect on
these echocardiographic indices itself, it signiﬁcantly alleviated or miti-
gated high fat diet-induced echocardiographic changes. These ﬁndings
implicated potential therapeutic beneﬁcial role of PTP1B knockout
against diet-induced cardiac anomalies.
3.2. Effect of PTP1B knockout on cardiomyocyte mechanics following high
fat diet feeding
To further discern the effect of PTP1B knockout on fat diet intake-
induced cardiac responses, cardiomyocyte contractile function was
assessed in WT or PTP1B knockout mice with or without HFD diet
feeding. Our data depicted in Fig. 2 revealed comparable resting cell
length in cardiomyocytes fromWT and PTP1B knockout mice with nor-
mal diet intake. High fat diet intake for 20 weeks signiﬁcantly increased
resting cell length, suppressed peak shortening (PS), maximum velocity
of shortening/relengthening (±dL/dt) and prolonged time-to-90%
relengthening (TR90) without affecting time-to-PS (TPS). Although
PTP1B knockout itself did not alter the mechanical parameters tested,
it signiﬁcantly attenuated or obliterated high fat diet-induced changes
in cardiomyocyte contractile function (with the exception of a short-
ened TPS). To examine the role of intracellular Ca2+ homeostasis in
PTP1B knockout and/or high fat diet-induced cardiac contractileA
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Fig. 3. Effect of PTP1B knockout on high fat diet (HFD)-induced changes in intracellular Ca2+ h
sessment of intracellular Ca2+ handling. A: Resting Fura-2 ﬂuorescent intensity (FFI); B: electri
nential) and D: intracellular Ca2+ transient decay rate (bi exponential). Mean ± SEM, n = 80responses, intracellular Ca2+ handling was evaluated using the Fura-2
ﬂuorescence technique. Our data revealed that high fat diet intake sig-
niﬁcantly increased resting intracellular Ca2+ levels, decreased
electrically-stimulated rise in intracellular Ca2+ (ΔFFI) and prolonged
intracellular Ca2+ decay rates (both single and bi-exponentials), the ef-
fects of which were ablated by PTP1B knockout. PTPT1B knockout itself
did not overtly affect intracellular Ca2+ indices tested with the excep-
tion of a decreased resting Ca2+ level (Fig. 3).
3.3. Effect of PTP1B knockout on cardiac hypertrophy following high fat diet
feeding
Consistent with the increased heart weight and size (when normal-
ized to tibial length) following high fat diet intake, the cardiomyocyte
cross-sectional area was elevated with high fat diet feeding. Although
PTP1B knockout itself did not affect cardiomyocyte cross-sectional
area, it partially reversed high fat diet intake-induced rise in cardiomyo-
cyte cross-sectional area (Fig. 4A, B). Consistentwith the observed cardi-
ac hypertrophy, mRNA levels of the pro-hypertrophic fetal genes (ANP,
BNP,α-MHC and β-MHC)were overtly upregulated in myocardium fol-
lowing high fat diet intake, the effects of which were nulliﬁed by PTP1B
knockoutwithout little effect by PTP1B knockout itself (Fig. 4C–F). In ad-
dition, high fat diet intake signiﬁcantly upregulated the protein levels of
the pro-hypertrophic markers ANP and GATA4, the effects of which
were abrogated by PTP1B knockout with little effect from PTP1B knock-
out by itself (Fig. 4G–H).
3.4. Effect of PTP1B knockout on cardiac lipid accumulation following high
fat diet feeding
Evaluation of cardiac lipid accumulation using oil red O staining and
triglyceride inmyocardium revealed that high fat diet intake signiﬁcant-
ly promoted cardiac lipid accumulation, the effect of which was mitigat-
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knockout-induced beneﬁcial response in cardiac lipid accumulation in
the face of high fat diet intake, we evaluated selected genes involved in
myocardial fatty acid metabolism. Our results revealed that high fat
diet intake signiﬁcantly increased genes associated with cardiac fatty
acid synthesis such as FAS, SREBP1c, PPARα and PPARγ. While PTP1B
knockout itself failed to elicit any notable effect on these lipogenic
genes, it signiﬁcantly attenuated or abrogated high fat diet intake-
induced elevation in FAS, SREBP1c, PPARα and PPARγ (Fig. 5C–F).These observations revealed a role of controlled transcriptional activa-
tion of fatty acid synthesis genes in PTP1B knockout-offered protection
against high fat diet feeding-induced myocardial lipid accumulation.
3.5. Effect of PTP1B knockout on expression of PTP1B, AMPK, mTOR and
autophagy protein markers following high fat diet feeding
To examine the possible signaling mechanisms involved in
PTP1B knockout-conferred protection against fat diet-induced cardiac
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Fig. 5. Effect of PTP1B knockout on chronic high fat diet (HFD) intake-induced cardiac lipid accumulation. A: Representative images of oil red O staining depicting cardiac lipid deposition;
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Beclin-1, p62 and LC3-II aswell as the autophagy stimulating AMPK sig-
naling cascade including AMPK, mTOR, and raptor were assessed. Our
results indicated that high fat diet feeding markedly upregulated levels
of PTP1B and the autophagosome adaptor p62 as well as decreased
Beclin-1 level and the LC3-II-to-LC3-I ratio, the effect ofwhichwas abro-
gated by PTP1B knockout (Fig. 6A–G). Furthermore, chronic high fat diet
intake signiﬁcantly suppressed phosphorylation of AMPK and raptor
while it signiﬁcantly increased phosphorylation of mTOR, the effects
were ablated by PTP1B knockout with little effect from PTP1B knockout
by itself (Fig. 6H–P). Theseﬁndings strongly favored a role of theAMPK–
mTOR-autophagy signaling cascade in fat diet intake and/or PTP1B
knockout-induced changes in myocardial autophagy.
3.6. Effect of AMPK inhibition on PTP1B knockout-induced cardioprotection
In order to consolidate a beneﬁcial role of AMPK activation in PTP1B
knockout-elicited cardioprotection against high fat intake, isolatedcardiomyocytes from WT and PTP1B knockout mice were incubated
with palmitic acid (PA, 75 μM for 2 h) [33] in the presence or absence
of the selective AMPK inhibitor compound C (5 μM). Our data depicted
in Fig. 7 revealed that palmitic acid signiﬁcantly depressed PS, ±dL/dt
and prolonged TR90 without affecting resting cell length and TPS, in a
manner reminiscent of chronic fat diet intake. As expected, PTP1B
knockout obliterated palmitic acid-induced cardiomyocyte contractile
anomalies. Interestingly, the PTP1B knockout-offered beneﬁcial cardio-
myocyte contractile response against palmitic acid was negated by
compound C. The AMPK inhibitor failed to affect cardiomyocyte me-
chanics by itself. These data favor a permissive role for AMPK activation
in PTP1B knockout-conferred cardioprotection against high fat diet
intake-induced cardiac contractile dysfunction.
4. Discussion
The salient ﬁndings from our study indicated that high fat diet feed-
ing leads to obesity, cardiac hypertrophy, contractile defect, impaired
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fects of which were alleviated or mitigated by PTP1B knockout. Our re-
sults further revealed that PTP1B knockout effectively restored the
dampened phosphorylation of AMPK and hyperactivated phosphoryla-
tion of mTOR and Raptor following high fat diet feeding. These data
were further supported by high fat diet-induced downregulation of
Beclin-1, LC3-II conversion as well as p62 accumulation, favoring the
presence of impaired autophagy initiation and autophagic ﬂux. Intrigu-
ingly, PTP1B knockout restored high fat diet-induced compromised au-
tophagy and autophagic ﬂux, suggesting a role of autophagy regulation
in PTP1B-conferred cardioprotection. Last but not least, the PTP1B
knockout-offered cardioprotection was negated by AMPK inhibition
using compound C, suggesting a permissive role of AMPK activation in
PTP1B knockout-preserved cardiac function under high fat diet intake.
Taken together, these ﬁndings revealed that PTP1B inhibition may be
protective against high fat diet-induced obesity cardiomyopathy possi-
bly through facilitation of AMPK-mediated autophagy.
Obesity, if uncorrected, leads to the onset and development of cardi-
ac hypertrophy and diastolic dysfunction [30,38,39], in accordancewith
enhanced levels of hypertrophic mRNA and protein seen in our current
study. Findings from our study revealed that chronic high fat diet intake
promoted development of obesity, cardiac remodeling (increased
LVEDD, LVESD and wall thickness), increased heart weight and size,cardiomyocyte area and cardiac dysfunction as evidenced by decreased
fractional shortening, peak shortening, ±dL/dt and prolonged TR90.
These ﬁndings are consistent with our earlier ﬁndings of compromised
myocardial contractile function following prolonged high fat diet feed-
ing [29,30,40]. Assessment of intracellular Ca2+ handling revealed de-
creased intracellular Ca2+ release upon electrical stimulation and
reduced intracellular Ca2+ clearance. These ﬁndings favor an essential
role of intracellular Ca2+ derangement in obesity-associated contractile
dysfunction. Interestingly PTP1B knockout effectively alleviated or mit-
igated high fat diet-induced cardiac remodeling, contractile and intra-
cellular Ca2+ anomalies, suggesting a unique role of PTP1B in the
onset and development of cardiac geometric and functional defects in
fat diet-induced obesity. It was noteworthy that PTP1B knockout exerts
its beneﬁcial effect against high fat diet feeding-induced cardiac anom-
alies independent of systemic regulation of blood glucose and insulin
levels.
PTP1B has been implicated in the regulation of glucose and lipidme-
tabolism as well as the onset and development of obesity and diabetes
[19,23,41,42]. Hoggard and colleagues found overtly elevated PTP1B
levels in obese and diabetic individuals [43]. In addition, ample of exper-
imental studies have demonstrated elevated PTP1B levels in various tis-
sues including brain [19,44–46], liver [47–49], and adipose tissues [50]
in obesity and diabetes. Global knockout of PTP1B was reported to
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beneﬁcial effect of pharmacological inhibition or genetic deletion of
PTP1B in heart failure [42]. Along the same line, we noted an increased
myocardial PTP1B levels following chronic high fat diet feeding. In our
hands, PTP1B knockout reduced cardiac lipid accumulation as well as
levels of fatty acid synthesis genes including FAS, SREBP1c, PPARα and
PPARγ following high fat diet intake, indicating regulation (suppres-
sion) of fatty acid synthesis by PTP1B knockout. These results are well
in line with the previous ﬁndings of decreased fatty acid synthesis
gene with liver-speciﬁc PTP1B knockout [47]. Furthermore, our results
demonstrated that PTP1B deletion restored high fat diet intake-
induced dephosphorylation of AMPK, favoring a role of AMPK signaling
in the regulation of lipidmetabolism and accumulation. It is well known
that impaired AMPK signaling prompts altered cardiac substrate prefer-
ence from fatty acids to carbohydrates, resulting in excessive fatty acid
synthesis, transport and accumulation in cardiac tissue [35].
In our hands, PTP1B deletion restored high fat diet intake-induced
dephosphorylation of AMPK. This is supported by our in vitro observa-
tion that PTP1B knockout-elicited beneﬁcial cardiac response against
palmitic acid may be nulliﬁed by compound C. Numerous studies have
depicted a role of AMPK in the regulation of cardiac hypertrophy [52,53]. Indeed, our earlier studies using AMPK kinase dead and adiponectin
knockout mice consolidated an essential role of AMPK in onset and de-
velopment of cardiac hypertrophy in the setting of high fat diet intake
[29,34]. On the other hand, experimental evidence was present to
argue against the notion that AMPK activation suppresses progression
of cardiac hypertrophy independent of inhibition of pro-hypertrophic
signaling [54,55]. In this context our results support the former, and
for the ﬁrst time, our data showed that PTP1B knockout retards fat
diet obesity-induced cardiac hypertrophy corroboratingwith a suppres-
sive action of PTP1B deletion against pro-hypertrophic signaling mole-
cules. PTP1B deletion is believed to promote AMPK activity through
increasing AMPK/ATP ratio and LKB1 levels. Although it is not clear
how these AMPK modulating events are activated, global deletion of
PTP1B increases AMPK α2 protein expression and activity without af-
fecting AMPKα1 expression or activity in brown adipose tissues and
skeletal muscles [46]. Along the same line, PTP1B inhibition promotes
AMPK-mediated brown fat differentiation through the AMPK
upstream signaling protein LKB1 [56]. One other explanation for
increased AMPK activity may be related to leptin sensitivity in the
face of PTP1B deletion or inhibition [57] although further investiga-
tion is warranted.
308 M.R. Kandadi et al. / Biochimica et Biophysica Acta 1852 (2015) 299–309Our ﬁndings depicted that high fat diet intake compromised myo-
cardial autophagy as evidenced by decreased Atg5, Beclin-1, and LC3II
conversion (LC3II/LC3I ratio) with increased p62. PTP1B knockout at-
tenuated p62 accumulation and restored Atg5, Beclin-1 expression
and LC3II conversion under high fat diet intake, suggesting a potential
role of improved autophagy in PTP1B knockout-conferred beneﬁcial
effect against high fat diet. Autophagy is regulated by multiple cell sig-
naling pathways including ROS, ER stress, p53 and AMPK under physio-
logical and pathophysiological conditions [58–60]. One major signaling
pathway regulating autophagy in obesity may be AMPK–mTOR
signaling where phosphorylated AMPK either phosphorylates raptor
or inhibits mTORC1 through phosphorylation of TSC2. In addition, acti-
vated AMPK promotes autophagy through phosphorylation of ULK1 at
Ser317 and Ser777 [61]. Our results revealed that high fat diet intake
inhibited phosphorylation of AMPK and Raptor and promoted mTOR
phosphorylation, resulting in inhibition of the autophagy initiation pro-
tein Atg5 and Beclin-1. Intriguingly, PTP1B knockout promoted autoph-
agy as evidenced by increased AMPK–raptor phosphorylation.
Experimental limitations: Several limitations should be noted for
our present study. First and foremost, PTP1B knockout retards high fat
diet-induced body weight gain, thus prompting a possible cardiac
response secondary to the PTP1B knockout-elicited global metabolic
response. Although our in vitro observation favors a unique effect of
PTP1B deletion against palmitic acid-induced cardiac anomalies, caution
has to be taken with regards to the contribution of PTP1B deletion-
elicited global effect. Second, the use of palmitic acid may trigger ER
stress, which may contribute to the regulation of autophagy. Possible
contribution of ER stress to fat diet intake and/or palmitic acid-
induced suppression of autophagy should not be discounted at this
time.
In summary, data fromour study offer evidence that PTP1Bmay play
a crucial role in high fat diet-induced cardiac hypertrophy and contrac-
tile dysfunction through an AMPK-dependent regulation of autophagy.
Restoration of autophagy with PTP1B knockout nulliﬁed undesirable
cardiac geometric and functional sequelae in the realm of fat diet-
induced obesity. These ﬁndings should shed some lights toward the eti-
ology of aberrant myocardial function and remodeling in diet-induced
obesity, and more importantly, the therapeutic potential of PTP1B
inhibition. In particular, special effort should be engaged in the estab-
lishment of PTP1B and autophagy as novel targets for the management
of obesity and associated complications.
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